Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Circulating Plasma Levels of Bone Morphogenic Protein Antagonist Gremlin-1 Are Increased in Patients with Pulmonary Arterial Hypertension

Jasmin Wellbrock, Ph.D., Jan K. Hennigs, M.D., Björn Schulz, Gabi Vohwinkel, M.Sc., Hans Jörg Baumann, M.D., Carsten Bokemeyer, M.D., Hans Klose, M.D., Walter Fiedler, MD, Nicole Lüneburg, Ph. D.

Blood (2012) 120 (21): 5189.

https://doi.org/10.1182/blood.V120.21.5189.5189

Published: 2012

Journal Articles

Gremlin-1 Is Overexpressed in Endothelial Cells of Patients with Loeys-Dietz Syndrome Due to Dysregulation of TGF-β Signalling,

Jasmin Wellbrock, PhD, Sara Sheikhzadeh, MD, Veronika Bonk, Leticia Oliveira-Ferrer, PhD, Kristin Klaetschke, Thomas Streichert, MD, Carsten Bokemeyer, M.D., Yskert von Kodolitsch, MD, Walter Fiedler, M.D.

Blood (2011) 118 (21): 3269.

https://doi.org/10.1182/blood.V118.21.3269.3269

Published: 2011

Journal Articles

Gremlin: vexing VEGF receptor agonist

Lena Claesson-Welsh

Blood (2010) 116 (18): 3386–3387.

https://doi.org/10.1182/blood-2010-09-299412

Published: 2010

Journal Articles

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2

Stefania Mitola, Cosetta Ravelli, Emanuela Moroni, Valentina Salvi, Daria Leali, Kurt Ballmer-Hofer, Luca Zammataro, Marco Presta

Blood (2010) 116 (18): 3677–3680.

https://doi.org/10.1182/blood-2010-06-291930

Published: 2010

Includes: Supplemental data

Journal Articles

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor

Helena Stabile, Stefania Mitola, Emanuela Moroni, Mirella Belleri, Stefania Nicoli, Daniela Coltrini, Francesco Peri, Antonello Pessi, Laura Orsatti, Fabio Talamo, Vincent Castronovo, David Waltregny, Franco Cotelli, Domenico Ribatti, Marco Presta

Blood (2006) 109 (5): 1834–1840.

https://doi.org/10.1182/blood-2006-06-032276

Published: 2006

Includes: Supplemental data

Journal Articles

Myeloma Cells Block Runx2/Cbfa1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation.

Nicola Giuliani, MD, PhD, Simona Colla, PhD, Francesca Morandi, PhD, Sabrina Bonomini, PhD, Vittorio Rizzoli, MD, PhD

Blood (2004) 104 (11): 632.

https://doi.org/10.1182/blood.V104.11.632.632

Published: 2004

NARROW

Circulating Plasma Levels of Bone Morphogenic Protein Antagonist Gremlin-1 Are Increased in Patients with Pulmonary Arterial Hypertension

Gremlin-1 Is Overexpressed in Endothelial Cells of Patients with Loeys-Dietz Syndrome Due to Dysregulation of TGF-β Signalling,

Gremlin: vexing VEGF receptor agonist

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor

Myeloma Cells Block Runx2/Cbfa1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation.

Email alerts

ASH Publications

American Society of Hematology

Circulating Plasma Levels of Bone Morphogenic Protein Antagonist Gremlin-1 Are Increased in Patients with Pulmonary Arterial Hypertension

Gremlin-1 Is Overexpressed in Endothelial Cells of Patients with Loeys-Dietz Syndrome Due to Dysregulation of TGF-β Signalling,

Gremlin: vexing VEGF receptor agonist

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor

Myeloma Cells Block Runx2/Cbfa1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only